Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirya Rashid

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Shirya Rashid, David E Curtis, Rita Garuti, et al.
Plos One|August 11, 2011
Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)Sonia S Anand, Mark A Tarnopolsky, Shirya Rashid, et al.
Cardiovascular Research|March 17, 2016
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanismsHagai Tavori, Ilaria Giunzioni, Irene M Predazzi, et al.
The Journal of Pathology|September 4, 2015
Local effects of human PCSK9 on the atherosclerotic lesionIlaria Giunzioni, Hagai Tavori, Roman Covarrubias, et al.
Cell Metabolism|February 4, 2009
Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophyVíctor A Cortés, David E Curtis, Suja Sukumaran, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Shirya Rashid, David E Curtis, Rita Garuti, et al.
Plos One|August 11, 2011
Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)Sonia S Anand, Mark A Tarnopolsky, Shirya Rashid, et al.
Cardiovascular Research|March 17, 2016
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanismsHagai Tavori, Ilaria Giunzioni, Irene M Predazzi, et al.
The Journal of Pathology|September 4, 2015
Local effects of human PCSK9 on the atherosclerotic lesionIlaria Giunzioni, Hagai Tavori, Roman Covarrubias, et al.
Cell Metabolism|February 4, 2009
Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophyVíctor A Cortés, David E Curtis, Suja Sukumaran, et al.
Pageof 3